NCT06267924 - SENSE-VM: Safety and Effectiveness of a Novel Medical Device for Symptom Ease in Vestibular Migraines | Biotech Hunter

Enrollment

322

Participants

Timeline

Start Date

March 6, 2024

Primary Completion Date

December 9, 2024

Study Completion Date

January 8, 2025

Conditions

Vestibular MigraineMigraine Associated Vertigo

Interventions

DEVICE

Otoband Experimental

Participants will be randomly assigned to use the Otoband Experimental device to determine effectiveness in providing temporary relief to symptoms of vertigo.

DEVICE

Otoband Sham

Participants will be randomly assigned to use the Otoband Sham device to determine effectiveness in providing temporary relief to symptoms of vertigo.

Trial Locations (1)

20001

Otolith Labs, Washington D.C.